Back to Evidence Hub
Case Study S034
2022 Release

Ganti 2022: Stroke Volume in CHD

V. Ganti et al.
Access Paper

Quick Conclusion: S034 is an important feasibility study that tests SCG in a complex patient population (CHD). By using Cardiac MRI as a comparator, it establishes a benchmark for non-invasive Stroke Volume monitoring in remote scenarios, while highlighting the benefit of multi-modal sensing.


📊 Key Accuracy Metrics

MetricResult
SV Error28% (with respect to CMR)
RMSE11.48 mL
R20.76


🔍 Study Analysis

Objective & Population

Observational Study / Feasibility Study. Cohort: Patients with congenital heart disease (CHD), children and adults (N=45).

What it Supports

The study demonstrates the feasibility of using wearable SCG (especially when integrated with ECG) to estimate Stroke Volume in patients with congenital heart disease. It shows a correlation (R2=0.76) with standard Cardiac MRI measurements.

What it Does Not Support

The study does not support the independent use of SCG for high-precision SV monitoring without ECG. The 28% error rate indicates it is more suitable for trending and monitoring than as a primary diagnostic tool.


🛠 Technical Context

Featured Illustration

Figure 1.  Concept overview. Study design showing wearable biosensor placement when supine and asynchronous reference cardiovascular magnetic resonance  imaging (CMR) measurement. Seismocardiogram (SCG) mechanistic overview detailing modulation due to cardiac physiology,  acquisition with an accelerometer, and sensing axes for ECG (negative, positive, and right-­leg-­drive [RLD] electrodes), and triaxial  SCG signals. Analysis pipeline, from sensor input to model estimation of stroke volume, for wearable (blue), demographic (green), and  CMR (purple) data. H indicates the transfer function between the input internal sources of cardiomechanical vibration and the output  SCG waveform measured on the surface of the torso; MRI, magnetic resonance imaging; and SCGdv, dorso-­ventral SCG.

Figure 1.  Concept overview. Study design showing wearable biosensor placement when supine and asynchronous reference cardiovascular magnetic resonance imaging (CMR) measurement. Seismocardiogram (SCG) mechanistic overview detailing modulation due to cardiac physiology, acquisition with an accelerometer, and sensing axes for ECG (negative, positive, and right-­leg-­drive [RLD] electrodes), and triaxial SCG signals. Analysis pipeline, from sensor input to model estimation of stroke volume, for wearable (blue), demographic (green), and CMR (purple) data. H indicates the transfer function between the input internal sources of cardiomechanical vibration and the output SCG waveform measured on the surface of the torso; MRI, magnetic resonance imaging; and SCGdv, dorso-­ventral SCG.

Study Snapshot

Metadata Summary

Target Population

Patients with congenital heart disease (CHD), children and adults

N

Sample Size

45 Subjects

Validated Metric

28% (with respect to CMR)

Critical Appraisal
supporting

Demonstrated feasibility of Stroke Volume estimation in CHD patients against MRI.